ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,230, issued on Sept. 29, was assigned to Aragon Pharmaceuticals Inc. (Horsham, Pa.).
"Anticancer compositions" was invented by Johny Bertels (Mol, Belgium), Matthieu Garin (Wemmel, Belgium), Florentina Maria Preda (Dessel, Belgium) and Reshema Kemps-Polanco (Titusville, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns pharmaceutical formulations of apalutamide, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (AR)-related disease or condition, in particular cancer, more in particular prostate cancer."
The patent was filed on May 23, 2025, under Application No. 19/21...